Summary

Report Scope
This report offers an overview of the global market for hyaluronic acid (HA) medical (or healthcare) products while also analyzing current market trends. The HA medical products covered in this report include HA dermal fillers, viscosupplements, dry eye treatments, ophthalmic viscoelastic devices (OVDs), regenerative products for wound care and musculoskeletal repair, anti-adhesion barriers and bulking agents for urology applications. The report covers only prescription products that may be used or recommended exclusively by qualified healthcare professionals in outpatient settings or during surgical procedures.
The report’s estimates of the HA medical products market include global revenue ($ millions) for the base year of 2024, estimates for 2025 and data for the forecast period of 2025 through 2030. The report focuses on the major trends, challenges and opportunities in the market and vendor landscape. It also covers the new products, acquisitions and collaborations related to the market. The report also analyzes environmental, social and corporate governance (ESG) developments.
The report concludes with an analysis of the competitive landscape, which provides a ranking by market share of leading companies in each HA medical product market. There is also a section of profiles of the leading companies.
Report Includes
- An overview of the global market for hyaluronic acid (HA) medical products
- In-depth analysis of global market trends, featuring historical revenue data from 2022-2024, estimated figures for 2025, as well as forecasts for 2030, including projections of compound annual growth rates (CAGRs) through 2030
- Analysis of market opportunities with a review of Porter’s Five Forces model and industry supply chain analysis, considering both micro- and macro environmental factors prevailing in the market
- Explanation of market drivers, restraints and other forces impacting the global market
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Identification of companies best positioned to meet this demand due to their proprietary technologies, mergers and acquisitions, and strategic initiatives
- Overview of sustainability trends and ESG developments, with emphasis on consumer attitudes, as well as the ESG risk ratings and practices of leading companies
- A relevant patent analysis, featuring key granted and published patents
- Profiles of the leading global companies, including AbbVie Inc., Galderma, Sanofi, Bioventus, IBSA Institut Biochimique S.A., and Fidia Farmaceutici S.p.A.

ページTOPに戻る

Table of Contents

Table of Contents
Chapter 1 Executive Summary
Market Outlook
Scope of Report
Market Summary
Market Dynamics
Emerging Trends
Analysis by Segment
Analysis by Region
Conclusion
Chapter 2 Market Overview
Hyaluronic Acid
Analysis of Macroeconomic Factors
Economic Growth and Income Levels
Impact of the U.S. Tariffs
Demographic Trends
Porter's Five Forces Analysis
Bargaining Power of Buyers: Moderate to High
Bargaining Power of Suppliers: Moderate
Threat of New Entrants: Moderate
Threat of Substitutes: Moderate to High
Industry Rivalry: Moderate
Chapter 3 Market Dynamics
Market Dynamics
Market Drivers
Expanding Clinical Applications of Hyaluronic Acid
Innovation and Biotechnological Advancements
Trend Toward Minimally Invasive Procedures
Market Challenges
High Cost and Short-Lasting Effects of HA
Potential Adverse Reactions and Side Effects
Market Trends
Microbial Fermentation-based HA Production
Hybrid Formulations of HA
Chapter 4 Regulatory Landscape
Overview
U.S.
European Union
Japan
China
Chapter 5 Emerging Technologies and Developments
Hyaluronic Acid as a Drug Delivery Vehicle
Three-Dimensional Bioprinting
Enzyme-based Hyaluronic Acid Synthesis
Clinical Trial Analysis
Key Takeaways
Chapter 6 Market Segmentation Analysis
Segmentation Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Product
Dermal Fillers
Viscosupplements
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Global Market for Hyaluronic Acid in Healthcare, by Source
Animal-derived HA
Microbial Fermentation
Geographic Breakdown
Global Market for Hyaluronic Acid in Healthcare, by Region
North America
Europe
Asia-Pacific
Middle East and Africa
South America
Chapter 7 Competitive Intelligence
Hyaluronic Acid Dermal Fillers
Key Takeaways
Market Share Analysis
Viscosupplements
Key Takeaways
Market Share Analysis
Ophthalmic Products
Regenerative and Anti-Adhesion Products
Bulking Agents for Urology Applications
Chapter 8 Sustainability in Hyaluronic Acid Market: An ESG Perspective
Introduction to ESG
Key ESG Issues Specific to Hyaluronic Acid Market
Environmental Impact of Single-Use Plastics in HA-based Treatments
Environmental Challenges of Large-Scale Microbial HA Production
Critical Role of Quality Control in Injectable HA Safety
Concluding Remarks
Chapter 9 Appendix
Methodology
Information Sources
Abbreviations
Company Profiles
ABBVIE INC.
ANIKA THERAPEUTICS INC.
BIOVENTUS
FERRING B.V.
FIDIA FARMACEUTICI S.P.A.
GALDERMA
IBSA INSTITUT BIOCHIMIQUE SA
MEDYTOX
MERZ PHARMA
NORDIC PHARMA
SANOFI
SANTEN PHARMACEUTICAL CO. LTD.
SEIKAGAKU CORP.
TEOXANE
URSAPHARM ARZNEIMITTEL GMBH
Emerging Start-ups/Market Disruptors